Page 14 - Vinay Umarji/undefined

Torrent Power Q4 PAT at Rs 398 cr versus Rs 274 cr loss a year ago

However, due to Covid-19 and power sector stress, consolidated income rose marginally by three per cent

BITSoM, London Business School partner for student immersions programme

BITSoM students to spend two weeks in London for immersion programme; Both parties will explore executive leadership programme only for India's women leaders

Health ministry panel vetting requests by six cos to make Mucormycosis drug

Development come amid fast spread of disease in various states and shortage of drugs to treat it; Rajasthan has already declared an epidemic

Torrent Pharma inks pact with Eli Lilly for Covid drug Baricitinib in India

Under royalty-free, non-exclusive deal, Torrent can make and sell baricitinib in India along with the US firm's other license partners

Eris Lifesciences Q4 PAT up 21% YoY on strong show by superspecialty biz

Consolidated total income up 13%; robust anti-diabetic sales, new product pipeline, expanded coverage of cardiologists support better numbers

Zydus Cadila to sell India animal health business for Rs 2,921 crore

We are sure that ZAHL will continue to grow and strengthen its position, said Pankaj Patel

Multiples Alternate Asset Mgt-led group to buy Cadila's animal health biz

The deal is to sell one of Cadila's two businesses on a slump sale basis as a going concern, for a lump sum of Rs 2,921 cr on cash-free and debt-free basis

RBI's Covid relief: Good move, but late, says health care industry

While some companies said they were open to borrowing, others felt their working capital cycle was comfortable

APSEZ Q4 PAT up by 288%; Adani Total Gas Q4 PAT up by 19%

Adani Ports' operating revenue for Q4FY21 grew by 24% to Rs 3,608 crore

Alembic Pharma Q4 net up 12% to Rs 251 cr on strong API, global businesses

Net sales rise 6% to Rs 1,280 cr; API business expands by as much as 38%

Torrent Power bags 300 Mw long-term solar power generation PPA

To be commissioned in 18 months from the date of PPA, the project will have a tariff of Rs 2.22/kwH for 25 years

States seek clarity on Covid vaccine price as they gear up for phase 3

Limited supply of vaccines could scupper move to open up vaccination to 18-plus

The much touted Gujarat model under scanner as second Covid-19 wave stings

As of mid-April, Gujarat had crossed 5,000 deaths since the pandemic first hit. The clogged health infrastructure, in terms of bed occupancies, has been alarming

Behind India's ventilator crisis: Lack of trained staff and idle units

Oxygen makers flag concern over shortage of liquid oxygen

The second wave: Covid-19 testing labs look at ways to ramp up capacity

Now demand is growing almost 100 per cent week-on-week, leading to a testing crisis, said an industry insider.

Aon Survey projects 6% salary hike in 2021 for senior executives in India

Study analysed 504 firms from over 20 industries. Variable pay plus LTI as a percentage of total compensation is 52% of CEOs in India compared to 87% in the US

Second Covid-19 wave: Hospitals running out of beds, staff overstretched

A year later, non-Covid treatments fall off priority list again

Top private sector healthcare body urges scaling up Covid vaccination drive

Wants private diagnostics labs, home care providers as part of inoculation process; calls for setting up vaccination centres in RWAs, malls, schools, airports, and large companies with space and staff

Alembic Pharma's injectables plant launch may face some delay

Company saw Form 483 with observations issued by US FDA for injectables plant in February

Zydus seeks DCGI nod for add'l indication of Hep C drug in Covid-19 therapy

In a likely breakthrough, interim results indicate that PegIFN when administered early on, could help patients recover faster and avoid complications seen in advanced Covid stages